Published in TB and Outbreaks Week, October 11th, 2005
The studies, which follow promising results for the vaccine obtained in animal studies, are scheduled to start in Europe, the U.S., and Africa in the second quarter of 2006.
The announcement was made by Crucell Chief Scientific Officer Dr. Jaap Goudsmit, at a congress held in Berlin, Germany, called "New Approaches to Vaccine Development - From the Bench to the Field."
Goudsmit's lecture, entitled "Children's Vaccines Against HIV, Malaria...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week